Trial · NCT00625404
Results by group24
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 24
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| HIV Infection | Truvada Arm | 33 | 3.25 to 6.63 | participants | |
| HIV Infection | Placebo Arm | 35 | 3.47 to 6.93 | participants | |
| Confirmed Grade 2 or Higher Serum Creatinine Toxicity | Truvada Arm | 4 | participants | ||
| Confirmed Grade 2 or Higher Serum Creatinine Toxicity | Placebo Arm | 2 | participants | ||
| Frequency of Adverse Events (AEs) During and Within 4 Weeks After Study Product Administration | Truvada Arm | 2257 | Number of adverse events | ||
| Frequency of Adverse Events (AEs) During and Within 4 Weeks After Study Product Administration | Placebo Arm | 2384 | Number of adverse events | ||
| Confirmed Grade 3 or Higher Reduction in Phosphorus | Truvada Arm | 45 | participants | ||
| Confirmed Grade 3 or Higher Reduction in Phosphorus | Placebo Arm | 40 | participants | ||
| Confirmed Grade 3 or Higher ALT Elevation | Truvada Arm | 6 | participants | ||
| Confirmed Grade 3 or Higher ALT Elevation | Placebo Arm | 8 | participants | ||
| Confirmed Grade 3 or Higher AST Elevation | Truvada Arm | 3 | participants | ||
| Confirmed Grade 3 or Higher AST Elevation | Placebo Arm | 1 | participants | ||
| Plasma HIV RNA Level (HIV-1 Viral Load) | Truvada Arm | 4.40 | Standard Deviation 1.05 | log copies/mL | |
| Plasma HIV RNA Level (HIV-1 Viral Load) | Placebo Arm | 4.37 | Standard Deviation 1.08 | log copies/mL | |
| CD4+ T-cell Count | Truvada Arm | 579.3 | Standard Deviation 318.2 | cells/mL | |
| CD4+ T-cell Count | Placebo Arm | 601.4 | Standard Deviation 318.5 | cells/mL | |
| FTC and/or Tenofovir Resistance | Truvada Arm | 3 | participants | ||
| FTC and/or Tenofovir Resistance | Placebo Arm | 1 | participants | ||
| Pregnancy Complications | Truvada Arm | 20 | participants | ||
| Pregnancy Complications | Placebo Arm | 10 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00625404/results